4
views
0
recommends
+1 Recommend
1 collections
    0
    shares

      To submit your manuscript, please click here

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Telemedicine for Adults With Cochlear Implants in the United Kingdom (CHOICE): Protocol for a Prospective Interventional Multisite Study

      research-article
      , BSc, MA, MSc, PhD 1 , , , BMusPerf, MSc, PhD 2 , , MSc 3 , , PhD 4 , , BSc, MSc, CPsychol, PhD 5 , 1 , , BSc, PhD 6 , , BSc, MSc, MA, PhD 7 , , BSc, MSc, PhD 3
      (Reviewer), (Reviewer), (Reviewer)
      JMIR Research Protocols
      JMIR Publications
      cochlear implants, hearing, deafness, telemedicine, patient-centered care

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Cochlear implants provide hearing to approximately 750,000 people with deafness worldwide; these patients require lifelong follow-up. Care for adults with implants in the United Kingdom occurs at one of 19 centers, which may be far from the patients’ homes. In a previous randomized controlled trial, we successfully introduced person-centered care. We designed, implemented, and evaluated the following remote care pathway: a personalized web-based support tool, home hearing check, self–device adjustment, and upgrading of sound processors at home rather than in the clinic. The remote care group had a significant increase in empowerment after using the tools, and the patients and clinicians were keen to continue. We would now like to scale up these improvements as an option for >12,000 UK adults using implants; we are commissioning an independent evaluation of this intervention and rollout to establish if it achieves its aims of more empowered and confident patients; more accessible and equitable care; stable hearing; more efficient, person-centered, and scalable service; and more satisfied and engaged patients and clinicians.

          Objective

          This study aims to evaluate the impact and rollout of a person-centered clinical care pathway via telemedicine for adults with cochlear implants in the United Kingdom, using both outcomes and process evaluation.

          Methods

          This project will scale up and evaluate a person-centered long-term follow-up pathway for adults using cochlear implants through a personalized website, including a home hearing check, uploading photos of cochlear implant site, listening in noise and music practice, ordering of spares, questionnaires, and other resources. Both quantitative and qualitative analyses will be conducted, and they will be both an outcome and process evaluation.

          Results

          As of July 2021, the trial is closed, and all data collection is complete. The evaluation report is expected to be published in December 2021, and the research data have not yet been analyzed.

          Conclusions

          This project will present the results of the first scaling up of a remote care pathway for adults with cochlear implants in the United Kingdom.

          Trial Registration

          International Standard Randomized Controlled Trial Number ISRCTN51668922; https://www.isrctn.com/ISRCTN51668922

          International Registered Report Identifier (IRRID)

          DERR1-10.2196/27207

          Related collections

          Most cited references42

          • Record: found
          • Abstract: found
          • Article: not found

          Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)

          Purpose This article introduces the new 5-level EQ-5D (EQ-5D-5L) health status measure. Methods EQ-5D currently measures health using three levels of severity in five dimensions. A EuroQol Group task force was established to find ways of improving the instrument’s sensitivity and reducing ceiling effects by increasing the number of severity levels. The study was performed in the United Kingdom and Spain. Severity labels for 5 levels in each dimension were identified using response scaling. Focus groups were used to investigate the face and content validity of the new versions, including hypothetical health states generated from those versions. Results Selecting labels at approximately the 25th, 50th, and 75th centiles produced two alternative 5-level versions. Focus group work showed a slight preference for the wording ‘slight-moderate-severe’ problems, with anchors of ‘no problems’ and ‘unable to do’ in the EQ-5D functional dimensions. Similar wording was used in the Pain/Discomfort and Anxiety/Depression dimensions. Hypothetical health states were well understood though participants stressed the need for the internal coherence of health states. Conclusions A 5-level version of the EQ-5D has been developed by the EuroQol Group. Further testing is required to determine whether the new version improves sensitivity and reduces ceiling effects.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Shared Decision Making: A Model for Clinical Practice

            The principles of shared decision making are well documented but there is a lack of guidance about how to accomplish the approach in routine clinical practice. Our aim here is to translate existing conceptual descriptions into a three-step model that is practical, easy to remember, and can act as a guide to skill development. Achieving shared decision making depends on building a good relationship in the clinical encounter so that information is shared and patients are supported to deliberate and express their preferences and views during the decision making process. To accomplish these tasks, we propose a model of how to do shared decision making that is based on choice, option and decision talk. The model has three steps: a) introducing choice, b) describing options, often by integrating the use of patient decision support, and c) helping patients explore preferences and make decisions. This model rests on supporting a process of deliberation, and on understanding that decisions should be influenced by exploring and respecting “what matters most” to patients as individuals, and that this exploration in turn depends on them developing informed preferences.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              When and how should multiple imputation be used for handling missing data in randomised clinical trials – a practical guide with flowcharts

              Background Missing data may seriously compromise inferences from randomised clinical trials, especially if missing data are not handled appropriately. The potential bias due to missing data depends on the mechanism causing the data to be missing, and the analytical methods applied to amend the missingness. Therefore, the analysis of trial data with missing values requires careful planning and attention. Methods The authors had several meetings and discussions considering optimal ways of handling missing data to minimise the bias potential. We also searched PubMed (key words: missing data; randomi*; statistical analysis) and reference lists of known studies for papers (theoretical papers; empirical studies; simulation studies; etc.) on how to deal with missing data when analysing randomised clinical trials. Results Handling missing data is an important, yet difficult and complex task when analysing results of randomised clinical trials. We consider how to optimise the handling of missing data during the planning stage of a randomised clinical trial and recommend analytical approaches which may prevent bias caused by unavoidable missing data. We consider the strengths and limitations of using of best-worst and worst-best sensitivity analyses, multiple imputation, and full information maximum likelihood. We also present practical flowcharts on how to deal with missing data and an overview of the steps that always need to be considered during the analysis stage of a trial. Conclusions We present a practical guide and flowcharts describing when and how multiple imputation should be used to handle missing data in randomised clinical. Electronic supplementary material The online version of this article (10.1186/s12874-017-0442-1) contains supplementary material, which is available to authorized users.
                Bookmark

                Author and article information

                Contributors
                Journal
                JMIR Res Protoc
                JMIR Res Protoc
                ResProt
                JMIR Research Protocols
                JMIR Publications (Toronto, Canada )
                1929-0748
                April 2022
                13 April 2022
                : 11
                : 4
                : e27207
                Affiliations
                [1 ] University of Southampton Auditory Implant Service University of Southampton Southampton United Kingdom
                [2 ] Nottingham Hearing Biomedical Research Unit National Institute for Health Research Nottingham United Kingdom
                [3 ] Wessex Academic Health Science Network Southampton United Kingdom
                [4 ] Northumbria University Newcastle upon Tyne United Kingdom
                [5 ] Centre for Clinical and Community Applications of Health Psychology University of Southampton Southampton United Kingdom
                [6 ] School of Electronics and Computer Science University of Southampton Southampton United Kingdom
                [7 ] School of Health Sciences University of Southampton Southampton United Kingdom
                Author notes
                Corresponding Author: Helen Cullington h.cullington@ 123456soton.ac.uk
                Author information
                https://orcid.org/0000-0002-5093-2020
                https://orcid.org/0000-0001-8383-5318
                https://orcid.org/0000-0002-1443-2344
                https://orcid.org/0000-0001-8647-735X
                https://orcid.org/0000-0002-3662-1488
                https://orcid.org/0000-0002-4562-9836
                https://orcid.org/0000-0001-6251-8786
                https://orcid.org/0000-0001-8801-8093
                https://orcid.org/0000-0002-2503-5432
                Article
                v11i4e27207
                10.2196/27207
                9047741
                35416780
                2ca0a208-2b7a-4338-8567-7d6aefdef4b1
                ©Helen Cullington, Padraig Kitterick, Philippa Darnton, Tracy Finch, Kate Greenwell, Carol Riggs, Mark Weal, Dawn-Marie Walker, Andrew Sibley. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 13.04.2022.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on https://www.researchprotocols.org, as well as this copyright and license information must be included.

                History
                : 18 January 2021
                : 17 May 2021
                : 26 July 2021
                : 31 December 2021
                Categories
                Protocol
                Protocol

                cochlear implants,hearing,deafness,telemedicine,patient-centered care

                Comments

                Comment on this article